McClure Barbara J, Hercus Timothy R, Cambareri Bronwyn A, Woodcock Joanna M, Bagley Christopher J, Howlett Geoff J, Lopez Angel F
Cytokine Receptor Laboratory and Protein Laboratory, Division of Human Immunology, Institute of Medical and Veterinary Science (IMVS), Adelaide, South Australia.
Blood. 2003 Feb 15;101(4):1308-15. doi: 10.1182/blood-2002-06-1903. Epub 2002 Oct 10.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic cytokine that stimulates the production and functional activity of granulocytes and macrophages, properties that have encouraged its clinical use in bone marrow transplantation and in certain infectious diseases. Despite the importance of GM-CSF in regulating myeloid cell numbers and function, little is known about the exact composition and mechanism of assembly of the GM-CSF receptor complex. We have now produced soluble forms of the GM-CSF receptor alpha chain (sGMRalpha) and beta chain (sbetac) and utilized GM-CSF, the GM-CSF antagonist E21R (Glu21Arg), and the betac-blocking monoclonal antibody BION-1 to define the molecular assembly of the GM-CSF receptor complex. We found that GM-CSF and E21R were able to form low-affinity, binary complexes with sGMRalpha, each having a stoichiometry of 1:1. Importantly, GM-CSF but not E21R formed a ternary complex with sGMRalpha and sbetac, and this complex could be disrupted by E21R. Significantly, size-exclusion chromatography, analytical ultracentrifugation, and radioactive tracer experiments indicated that the ternary complex is composed of one sbetac dimer with a single molecule each of sGMRalpha and of GM-CSF. In addition, a hitherto unrecognized direct interaction between betac and GM-CSF was detected that was absent with E21R and was abolished by BION-1. These results demonstrate a novel mechanism of cytokine receptor assembly likely to apply also to interleukin-3 (IL-3) and IL-5 and have implications for our molecular understanding and potential manipulation of GM-CSF activation of its receptor.
粒细胞-巨噬细胞集落刺激因子(GM-CSF)是一种造血细胞因子,可刺激粒细胞和巨噬细胞的产生及功能活性,这些特性促使其在骨髓移植和某些传染病的临床治疗中得到应用。尽管GM-CSF在调节髓样细胞数量和功能方面具有重要作用,但对于GM-CSF受体复合物的确切组成和组装机制却知之甚少。我们现已制备出GM-CSF受体α链(sGMRα)和β链(sβc)的可溶性形式,并利用GM-CSF、GM-CSF拮抗剂E21R(Glu21Arg)以及βc阻断单克隆抗体BION-1来确定GM-CSF受体复合物的分子组装情况。我们发现,GM-CSF和E21R能够与sGMRα形成低亲和力的二元复合物,其化学计量比均为1:1。重要的是,GM-CSF而非E21R能与sGMRα和sβc形成三元复合物,且该复合物可被E21R破坏。值得注意的是,尺寸排阻色谱法、分析超速离心法和放射性示踪实验表明,三元复合物由一个sβc二聚体以及一个sGMRα分子和一个GM-CSF分子组成。此外,还检测到βc与GM-CSF之间存在一种此前未被认识到的直接相互作用,而E21R不存在这种相互作用,且该相互作用可被BION-1消除。这些结果证明了一种细胞因子受体组装的新机制,这种机制可能也适用于白细胞介素-3(IL-3)和白细胞介素-5,并且对我们从分子层面理解GM-CSF对其受体的激活以及潜在的调控具有重要意义。